SCHEDULE: Radoff Entities Divest All Spruce Biosciences Shares

The Radoff Family Foundation and Bradley L. Radoff have reported a complete divestment of their beneficial ownership in Spruce Biosciences, Inc. as of June 30, 2025.

Summary

• Radoff Family Foundation and Bradley L. Radoff, the Reporting Persons, filed an Amendment No. 2 to Schedule 13G.
• As of the close of business on June 30, 2025, the Reporting Persons no longer beneficially owned any securities of Spruce Biosciences, Inc.
• Their aggregate beneficial ownership is 0 shares, representing 0% of the common stock class.
• This filing indicates a complete divestment of their previous holdings in the company.

Sentiment

Score: 3

Explanation: The complete divestment by a significant investor is a negative signal, suggesting a lack of confidence or a strategic exit, which could put downward pressure on the stock price.

Negatives

• A significant investor, Radoff Family Foundation and Bradley L. Radoff, has completely divested their holdings in Spruce Biosciences, Inc.
• This action may indicate a loss of confidence or a strategic portfolio reallocation by these investors.

Risks

• Investor confidence risk due to a complete divestment by a notable investor.
• Potential for negative market perception following the disclosure of a significant shareholder exit.

Industry Context

This filing reflects an investment decision by a specific entity rather than a broad industry trend. However, significant investor exits can sometimes signal concerns within a particular sector or company, especially in the volatile biotechnology industry where investor confidence is crucial.

Stakeholder Impact

• Shareholders: May experience decreased stock price due to perceived loss of investor confidence and potential selling pressure.
• Company Management: May face questions regarding the reasons for the significant investor's exit.

Key Dates

Recommendation

The complete divestment of shares by the Radoff Family Foundation and Bradley L. Radoff, who previously held a position, indicates a loss of confidence or a strategic decision to exit the investment. This action by a notable investor could signal underlying concerns about Spruce Biosciences, Inc.'s future prospects or performance, potentially leading to negative market sentiment and downward pressure on the stock price. For a seasoned investor, this would typically be a signal to consider selling or avoiding the stock.

Keywords

Spruce Biosciences, Radoff Family Foundation, Bradley L. Radoff, Schedule 13G, Beneficial Ownership, Divestment, Common Stock, SEC Filing, Biotechnology, Investment